HHV-8 Antibodies

Santa Cruz Biotechnology features a diverse variety of HHV-8 monoclonal antibodies for the detection and analysis of human herpesvirus 8, a key player in the development of Kaposi's sarcoma and other lymphoproliferative disorders. HHV-8 Antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HHV-8, also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is crucial for understanding the mechanisms of viral oncogenesis and the pathogenesis of associated diseases. The ability of HHV-8 to manipulate host cell signaling pathways and evade immune responses makes it a significant focus of research in virology and cancer biology. Understanding HHV-8 is essential for developing targeted therapies and improving diagnostic methods for related conditions. Research into HHV-8 continues to reveal new insights about viral mechanisms and potential therapeutic targets. Investigating HHV-8's role in disease progression helps advance our knowledge of virus-host interactions and immune system responses. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of HHV-8 and its impact on human health.